🔎 Trials Near Me

Pradžia › Antsvoris › Texas › Austin

Antsvoris klinikiniai tyrimai Austin, TX

18 tyrimai dėl Antsvoris ieško dalyvių vietose Austin ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai2 fazė
  • Elligo Clinical Research Center /ID# 282166, Austin
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Renkami dalyviai3 fazė
  • Texas Diabetes & Endocrinology, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Renkami dalyviai3 fazė
  • IMA Clinical Research Austin, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Renkami dalyviai3 fazė
  • Dell Children's Medical Center - PIN, Austin
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Renkami dalyviai3 fazė
  • IMA Clinical Research Austin, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Renkami dalyviai3 fazė
  • FutureSearch Trials of Neurology, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Renkami dalyviai3 fazė
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • IMA Clinical Research Austin, Austin
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Renkami dalyviai2 fazėLaukiami sveiki savanoriai
  • The University of Texas at Austin, Austin
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai3 fazė
  • AURORA-1 Clinical Site, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Renkami dalyviai3 fazė
  • AURORA-2 Clinical Site, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • ACCOMPLISH-2 Research Site, Austin
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • IMA Clinical Research Austin, Austin
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Renkami dalyviai3 fazė
  • Elligo Clinical Research Center, Austin
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Renkami dalyviai3 fazė
  • Elligo Clinical Research Center, Austin
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Renkami dalyviai3 fazė
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Renkami dalyviai1 fazė
  • Elligo Clin Res Centre, Austin
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-25 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Renkami dalyviai1 fazė
  • Corxel Investigational Site, Austin
Amžius nuo 18 iki 55 · Moterims · Atnaujinta 2026-06-17 · NCT07652047

Antsvoris tyrimai kituose miestuose

Kiti tyrimai Austin

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.